In the present study, we have measured bone marrow radioactivity using direct counting of tissues from normal rats and from tumor-bearing nude rats after intravenous injection ofradiolabeled intact Mabs or F(ab')2 fragments directed against carcinoembryonic antigen (CEA). Radia tion doses to bone marrow and different organs were calculated from time course radioactivity distribution studies in normal rats. The results were also compared with dosimetric studies performed in tumor-bearing nude mice in the course of successful radioimmunotherapy (8, 9). A good correlation was found for all organsanalyzed in the two species. In mice, however, radiation doses to bone marrow could not be measured. A good correlation was also obtained with ex...
Adequate dosimetry is mandatory for effective and safe peptide receptor radionuclide therapy (PRRT)....
have been used to treat bone pain. The limiting factor in this modality is marrow toxicity. Our hypo...
Targeted radionuclide therapy with 177Lu-DOTATATE for patients with neuroendocrine tumours utilises ...
Normal rats were injected intravenously with 131I- and 125I-labeled intact murine and chimeric mouse...
Purpose: Biokinetic and dosimetry studies in laboratory animals often precede clinical radionuclide ...
Hematologic toxicity limits the radioactivity that may be administered for radiolabeled antibody the...
BACKGROUND: The method for red marrow dosimetry in radioimmunotherapy, in the absence of specific ac...
Red marrow is usually the dose-limiting organ during radioimmunotherapy. Several non-invasive approa...
low uptake of radiolabeled antibodies in tumors, single photon emission computed tomography (SPECT) ...
Bone marrow is usually dose-limiting for radioimmunotherapy. In this study, we directly estimated re...
Counts of macroscopic splenic colonies were used to obtain an estimate of the radiation sensitivity ...
Description: Quantitative bone marrow transplantation was used to obtain an estimate of the radiatio...
Purpose: Adequate dosimetry is mandatory for effective and safe peptide receptor radionuclide therap...
<p>4-A: WBC counts. 4-B: RBC counts. 4-C: Hemoglobin counts. 4-D: PLT counts. 4-E: CFU-F counts in b...
The therapeutic efficacy of the -particle-emitting radionuclide 223Ra (t1/2 11.4 days) in the treat...
Adequate dosimetry is mandatory for effective and safe peptide receptor radionuclide therapy (PRRT)....
have been used to treat bone pain. The limiting factor in this modality is marrow toxicity. Our hypo...
Targeted radionuclide therapy with 177Lu-DOTATATE for patients with neuroendocrine tumours utilises ...
Normal rats were injected intravenously with 131I- and 125I-labeled intact murine and chimeric mouse...
Purpose: Biokinetic and dosimetry studies in laboratory animals often precede clinical radionuclide ...
Hematologic toxicity limits the radioactivity that may be administered for radiolabeled antibody the...
BACKGROUND: The method for red marrow dosimetry in radioimmunotherapy, in the absence of specific ac...
Red marrow is usually the dose-limiting organ during radioimmunotherapy. Several non-invasive approa...
low uptake of radiolabeled antibodies in tumors, single photon emission computed tomography (SPECT) ...
Bone marrow is usually dose-limiting for radioimmunotherapy. In this study, we directly estimated re...
Counts of macroscopic splenic colonies were used to obtain an estimate of the radiation sensitivity ...
Description: Quantitative bone marrow transplantation was used to obtain an estimate of the radiatio...
Purpose: Adequate dosimetry is mandatory for effective and safe peptide receptor radionuclide therap...
<p>4-A: WBC counts. 4-B: RBC counts. 4-C: Hemoglobin counts. 4-D: PLT counts. 4-E: CFU-F counts in b...
The therapeutic efficacy of the -particle-emitting radionuclide 223Ra (t1/2 11.4 days) in the treat...
Adequate dosimetry is mandatory for effective and safe peptide receptor radionuclide therapy (PRRT)....
have been used to treat bone pain. The limiting factor in this modality is marrow toxicity. Our hypo...
Targeted radionuclide therapy with 177Lu-DOTATATE for patients with neuroendocrine tumours utilises ...